STAT+: FDA announces sweeping changes to oversight of wea...
The FDA will ease regulation of digital health products, aiming to deregulate AI and promote its widespread use.
What’s Happening
Real talk: The FDA will ease regulation of digital health products, aiming to deregulate AI and promote its widespread use.
Politics Politics Trump tells Republicans to be flexible on abortion restrictions to get a health care deal By Associated Press D. Diagnosis STAT Plus: HHS slashes vaccine recommendations By John Wilkerson Health Health New vaccine schedule adds near- and long-term risks for children, the experts warn By Isabella Cueto Politics Politics STAT Plus: Federal appeals court upholds ruling blocking NIH cap on research overhead payments By Jonathan Wosen Politics Politics Federal health officials slash recommended childhood vaccinations under Trump’s directive By Chelsea Cirruzzo and Helen Branswell STAT Plus: The biotech scorecard for the first quarter: 26 stock-moving events to watch By Adam Feuerstein STAT Plus: What does Neuralink want — to help people with paralysis, or prepare for a war with AI? (and honestly, same)
Rose Broderick STAT Plus: AI has finally kicked off making drug-like antibodies.
Why This Matters
When will it revolutionize biopharma? By Brittany Trang STAT Plus: Who will pay for AI in health care?
Health experts are weighing in on what this means for people.
The Bottom Line
This story is still developing, and we’ll keep you updated as more info drops.
Sound off in the comments.
Daily briefing
Get the next useful briefing
If this story was worth your time, the next one should be too. Get the daily briefing in one clean email.
Reader reaction
